These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30195842)

  • 61. Impact of clinical and genetic findings on the management of young patients with Brugada syndrome.
    Andorin A; Behr ER; Denjoy I; Crotti L; Dagradi F; Jesel L; Sacher F; Petit B; Mabo P; Maltret A; Wong LC; Degand B; Bertaux G; Maury P; Dulac Y; Delasalle B; Gourraud JB; Babuty D; Blom NA; Schwartz PJ; Wilde AA; Probst V
    Heart Rhythm; 2016 Jun; 13(6):1274-82. PubMed ID: 26921764
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3.
    Kamakura S; Ohe T; Nakazawa K; Aizawa Y; Shimizu A; Horie M; Ogawa S; Okumura K; Tsuchihashi K; Sugi K; Makita N; Hagiwara N; Inoue H; Atarashi H; Aihara N; Shimizu W; Kurita T; Suyama K; Noda T; Satomi K; Okamura H; Tomoike H;
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):495-503. PubMed ID: 19843917
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Electrocardiographic characteristics of premature ventricular contractions in subjects with type 1 pattern of Brugada syndrome.
    Letsas KP; Asvestas D; Vlachos K; Karlis D; Korantzopoulos P; Efremidis M; Sideris A
    J Electrocardiol; 2014; 47(3):351-5. PubMed ID: 24636795
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Use, misuse, and pitfalls of the drug challenge test in the diagnosis of the Brugada syndrome.
    Wilde AAM; Amin AS; Morita H; Tadros R
    Eur Heart J; 2023 Jul; 44(27):2427-2439. PubMed ID: 37345279
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Predicting cardiac electrical response to sodium-channel blockade and Brugada syndrome using polygenic risk scores.
    Tadros R; Tan HL; ; El Mathari S; Kors JA; Postema PG; Lahrouchi N; Beekman L; Radivojkov-Blagojevic M; Amin AS; Meitinger T; Tanck MW; Wilde AA; Bezzina CR
    Eur Heart J; 2019 Oct; 40(37):3097-3107. PubMed ID: 31504448
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Significance of non-type 1 anterior early repolarization in patients with inferolateral early repolarization syndrome.
    Kamakura T; Kawata H; Nakajima I; Yamada Y; Miyamoto K; Okamura H; Noda T; Satomi K; Aiba T; Takaki H; Aihara N; Kamakura S; Kimura T; Shimizu W
    J Am Coll Cardiol; 2013 Oct; 62(17):1610-8. PubMed ID: 23850930
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cardiac electrophysiological substrate underlying the ECG phenotype and electrogram abnormalities in Brugada syndrome patients.
    Zhang J; Sacher F; Hoffmayer K; O'Hara T; Strom M; Cuculich P; Silva J; Cooper D; Faddis M; Hocini M; Haïssaguerre M; Scheinman M; Rudy Y
    Circulation; 2015 Jun; 131(22):1950-9. PubMed ID: 25810336
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prevalence and clinical course of the juveniles with Brugada-type ECG in Japanese population.
    Oe H; Takagi M; Tanaka A; Namba M; Nishibori Y; Nishida Y; Kawarabayashi T; Yoshiyama M; Nishimoto M; Tanaka K; Yoshikawa J
    Pacing Clin Electrophysiol; 2005 Jun; 28(6):549-54. PubMed ID: 15955188
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Insights into the location of type I ECG in patients with Brugada syndrome: correlation of ECG and cardiovascular magnetic resonance imaging.
    Veltmann C; Papavassiliu T; Konrad T; Doesch C; Kuschyk J; Streitner F; Haghi D; Michaely HJ; Schoenberg SO; Borggrefe M; Wolpert C; Schimpf R
    Heart Rhythm; 2012 Mar; 9(3):414-21. PubMed ID: 22119454
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The full stomach test as a novel diagnostic technique for identifying patients at risk of Brugada syndrome.
    Ikeda T; Abe A; Yusu S; Nakamura K; Ishiguro H; Mera H; Yotsukura M; Yoshino H
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):602-7. PubMed ID: 16836706
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Differences in 12-lead electrocardiogram between symptomatic and asymptomatic Brugada syndrome patients.
    Junttila MJ; Brugada P; Hong K; Lizotte E; DE Zutter M; Sarkozy A; Brugada J; Benito B; Perkiomaki JS; Mäkikallio TH; Huikuri HV; Brugada R
    J Cardiovasc Electrophysiol; 2008 Apr; 19(4):380-3. PubMed ID: 18081770
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Brugada syndrome.
    Korlipara H; Korlipara G; Pentyala S
    Acta Cardiol; 2021 Oct; 76(8):805-824. PubMed ID: 32684122
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Utility of 12-lead and signal-averaged Holter electrocardiograms after pilsicainide provocation for risk stratification in Brugada syndrome.
    Kakihara J; Takagi M; Hayashi Y; Tatsumi H; Doi A; Yoshiyama M
    Heart Vessels; 2017 Sep; 32(9):1151-1159. PubMed ID: 28364267
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Criteria for evaluating rSr' patterns due to high precordial ECG lead placement accurately confirm absence of a Brugada ECG pattern.
    Peritz DC; Chung EH
    J Electrocardiol; 2016; 49(2):182-6. PubMed ID: 26850497
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Spontaneous Brugada electrocardiogram patterns are rare in the German general population: results from the KORA study.
    Sinner MF; Pfeufer A; Perz S; Schulze-Bahr E; Mönnig G; Eckardt L; Beckmann BM; Wichmann HE; Breithardt G; Steinbeck G; Fabritz L; Kääb S; Kirchhof P
    Europace; 2009 Oct; 11(10):1338-44. PubMed ID: 19654127
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing.
    Crotti L; Marcou CA; Tester DJ; Castelletti S; Giudicessi JR; Torchio M; Medeiros-Domingo A; Simone S; Will ML; Dagradi F; Schwartz PJ; Ackerman MJ
    J Am Coll Cardiol; 2012 Oct; 60(15):1410-8. PubMed ID: 22840528
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Electrocardiographic parameters and fatal arrhythmic events in patients with Brugada syndrome: combination of depolarization and repolarization abnormalities.
    Tokioka K; Kusano KF; Morita H; Miura D; Nishii N; Nagase S; Nakamura K; Kohno K; Ito H; Ohe T
    J Am Coll Cardiol; 2014 May; 63(20):2131-2138. PubMed ID: 24703917
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Criteria to predict carriers of a novel SCN5A mutation in a large Portuguese family affected by the Brugada syndrome.
    Santos LF; Rodrigues B; Moreira D; Correia E; Nunes L; Costa A; Elvas L; Pereira T; Machado JC; Castedo S; Henriques C; Matos A; Santos JO
    Europace; 2012 Jun; 14(6):882-8. PubMed ID: 22277643
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Characterization of the epicardial substrate for catheter ablation of Brugada syndrome.
    Zhang P; Tung R; Zhang Z; Sheng X; Liu Q; Jiang R; Sun Y; Chen S; Yu L; Ye Y; Fu G; Shivkumar K; Jiang C
    Heart Rhythm; 2016 Nov; 13(11):2151-2158. PubMed ID: 27453126
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A novel prediction model for risk stratification in patients with a type 1 Brugada ECG pattern.
    Subramanian M; Prabhu MA; Rai M; Harikrishnan MS; Sekhar S; Pai PG; Natarajan KU
    J Electrocardiol; 2019; 55():65-71. PubMed ID: 31082614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.